🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/02/2014 | 53,44 | 53,86 | 53,36 | 53,69 | +0,64% | 0,95% | 10.626.196 |
| 25/02/2014 | 53,56 | 53,81 | 53,24 | 53,35 | -0,48% | 1,05% | 8.923.196 |
| 24/02/2014 | 53,31 | 54,31 | 53,31 | 53,61 | +0,27% | 1,88% | 11.541.100 |
| 21/02/2014 | 53,29 | 53,76 | 53,26 | 53,46 | +0,39% | 0,93% | 12.226.597 |
| 20/02/2014 | 52,59 | 53,44 | 52,51 | 53,25 | +1,40% | 1,76% | 10.619.489 |
| 19/02/2014 | 52,90 | 53,11 | 52,47 | 52,52 | -1,17% | 1,21% | 10.791.361 |
| 18/02/2014 | 52,69 | 53,37 | 52,61 | 53,14 | +0,45% | 1,45% | 11.738.753 |
| 14/02/2014 | 52,43 | 53,07 | 52,43 | 52,90 | +0,62% | 1,22% | 9.098.631 |
| 13/02/2014 | 51,96 | 52,68 | 51,92 | 52,58 | +0,18% | 1,47% | 10.735.083 |
| 12/02/2014 | 52,90 | 53,14 | 52,34 | 52,48 | -1,26% | 1,52% | 14.283.926 |
| 11/02/2014 | 52,20 | 53,20 | 51,95 | 53,15 | +1,48% | 2,39% | 16.089.525 |
| 10/02/2014 | 51,80 | 52,48 | 51,74 | 52,38 | +0,22% | 1,44% | 11.118.861 |
| 07/02/2014 | 51,19 | 52,31 | 50,99 | 52,26 | +1,86% | 2,57% | 15.192.961 |
| 06/02/2014 | 50,82 | 51,40 | 50,38 | 51,31 | +0,45% | 2,01% | 12.832.550 |
| 05/02/2014 | 51,79 | 52,67 | 50,71 | 51,08 | +0,04% | 3,80% | 25.682.602 |
| 04/02/2014 | 50,18 | 51,07 | 50,00 | 51,06 | +2,75% | 2,13% | 19.054.631 |
| 03/02/2014 | 50,49 | 50,72 | 49,54 | 49,69 | -1,68% | 2,32% | 16.232.053 |
| 31/01/2014 | 50,87 | 51,03 | 50,34 | 50,54 | -1,01% | 1,35% | 17.071.920 |
| 30/01/2014 | 50,06 | 51,21 | 49,98 | 51,06 | +2,49% | 2,46% | 18.205.646 |
| 29/01/2014 | 50,29 | 50,42 | 49,41 | 49,82 | -1,25% | 2,01% | 20.274.713 |
| 28/01/2014 | 49,97 | 50,66 | 49,83 | 50,45 | +0,65% | 1,66% | 15.801.954 |
| 27/01/2014 | 50,44 | 51,62 | 50,12 | 50,12 | +1,06% | 2,97% | 32.490.096 |
| 24/01/2014 | 48,92 | 49,78 | 48,79 | 49,60 | +0,74% | 2,03% | 19.137.842 |
| 23/01/2014 | 48,86 | 49,38 | 48,53 | 49,24 | +0,49% | 1,74% | 16.639.934 |
| 22/01/2014 | 49,40 | 49,60 | 48,93 | 49,00 | -0,93% | 1,35% | 11.164.973 |
| 21/01/2014 | 49,65 | 49,86 | 49,34 | 49,46 | -0,23% | 1,04% | 11.565.204 |
| 17/01/2014 | 50,21 | 50,24 | 49,35 | 49,57 | -1,05% | 1,77% | 17.563.222 |
| 16/01/2014 | 49,76 | 50,55 | 49,71 | 50,10 | -0,04% | 1,69% | 8.142.541 |
| 15/01/2014 | 50,24 | 50,48 | 49,95 | 50,11 | -0,91% | 1,04% | 10.991.424 |
| 14/01/2014 | 50,12 | 50,67 | 49,78 | 50,57 | -0,23% | 1,77% | 22.207.854 |